ÇÐÀ§³í¹®

µµ¼­°ü¼­ºñ½º

 

 

ÇÐÀ§³í¹®

 

 "³»°úÇÐÀü°ø" (À¸)·Î °Ë»öÇÑ °á°ú

±Þ¼º ½É±Ù °æ»öÁõ ȯÀÚÀÇ ÃÑ CK ¹× CK-MB À¯¸®·®°ú LDH ¹× LDH1 È°¼ºµµ »çÀÌÀÇ Nomogram

The nomgram between the total serum CK and CK-MB release and the activity of serum LDHand LDH1 parients of acute myocardial infarction

ÀúÀÚ : ±è½Ãȯ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1987  

°íºóµµ Jet ȯ±âÀÇ Ç÷¿ªÇÐÀû ¿µÇâ¿¡ °üÇÑ ¿¬±¸

Hemodynamic Effects of High Frequency Jet Ventilation in Normal Dogs

ÀúÀÚ : ±èųâ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1988  

´Ü¹é´¢¿¡ ´ëÇÑ CaptoprilÀÇ È¿°ú

The Effect of Captopril on Proteinuria

ÀúÀÚ : °í¸í±¸

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1988  

±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ¿¡¼­ QRS Á¡¼öÁ¦¿Í ÃÑcreatie kinase ¹× creatine kinase MB À¯¸®·®°úÀÇ °ü°è

Relation between a QRS scoring system and cumulative creatine kinase and creatine kinase MB release in the patient with acute myocardial infarction

ÀúÀÚ : ÀÌ¿µ°ï

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1988  

´¢Áõ C-peptideÀÇ ¸²»óÀû ÀÇÀÇ¿¡ °üÇÑ ¿¬±¸

A Study for Clinical Significance of Urinary C-peptide

ÀúÀÚ : ÃÖÁ¤±Ô

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1988  

Anti-HBc ´Üµ¶ ¾ç¼ºÀÚ¿¡¼­ GOT, GPTÄ¡ÀÇ ÀÌ»óÀ¯¹«¿¡ µû¸¥ anti-HBc titerÀÇ ºñ±³

The Titer of Anti-HBc in Subjects with Isolated Serum Anti-HBc

ÀúÀÚ : ±èÇÊ¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1988  

°£Áúȯ Áø´Ü¿¡ À־ ¼Òº¯³» ´ãÁó»ê ÃøÁ¤ÀÇ ÀÇÀÇ

Bile Acids in Random Sample of Urine in the Patients of Various Liver Disease

ÀúÀÚ : °ûö½Â

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1989  

°íºóµµ ȯ±â¹ý¿¡¼­ÀÇ ±âµµ ¹× ÆóÆ÷¾ÐÀÇ º¯È­

Changes of mean airway pressure and alveolar Pressure during HFJV

ÀúÀÚ : ¾ÈÀçÈñ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1989  

Tharacic electrical bioimpedance¸¦ ÀÌ¿ëÇÑ ½É¹ÚÃâ¾ç ÃøÁ¤ÀÇ À¯¿ë¼º¿¡ °üÇÑ ¿¬±¸

Usefulness of measurement of cardiac output by Thoracic Electical bioimpedance

ÀúÀÚ : Á¶ÀÎÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1989  

¿ø¹ß¼º °£¾Ï ȯÀÚÀÇ Novel r-GTP isoenzyme¿¡ ´ëÇÑ ¿¬±¸

NOVEL r-GTP ISOENZYME IN SERA OF PATIENTS WITH HEATOCELLULAR CRACINOMA

ÀúÀÚ : Á¤¹®È£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1989  

°íºóµµ Jetȯ±â¹ý¿¡ ÀÇÇÑ ÀΰøÈ£Èí½Ã Æäȯ±â¿¡ ¹ÌÄ¡´Â ÀÎÀÚ¿¡ °üÇÑ ¿¬±¸

Determinants of arterial PCO2 on high Frequency Jet Ventilation (HFJV)

ÀúÀÚ : ÀÌ°æÈñ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1989  

ÁÖ»çºÎÀ§¿¡ µû¸¥ Àν¶¸°Èí¼öÀÇ º¯µ¿

Aiteration in Insulin Absorption Associated with Varying Insulin Injection Sites

ÀúÀÚ : ±èÁ¾¸í

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1989  

´¢ C-peptide ÃøÁ¤¿¡ ´ëÇÑ amylaseÀÇ ¿µÇâ

The Effect of Amylase on Measurement of Urinary C-Peptide

ÀúÀÚ : µµÀÏȯ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1989  

Á¤»óÀÎ 20´ë ³²ÀÚ¿¡¼­ Holter ½ÉÀüµµ¸¦ ÀÌ¿ëÇÑ ºÎÁ¤¸Æ¿¡ °üÇÑ ¿¬±¸

A study of arrythmia using Holter EKG monitoring on normal males in their twenties

ÀúÀÚ : À±ºÀ¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

´Á¸·»ïÃâ ȯÀÚ¿¡ À־ Ç÷û°ú ´Á¸·¾×ÀÇ Adenosine Deaminase(ADA)¿Í Lysozyme È°¼ºÄ¡ÀÇ ÀÓ»óÀû ÀÇÀÇ

The Diagnostic Value of ADA and Lysozyme Activityin The Pleural Effusion Patients

ÀúÀÚ : ÀÌÀçÀÍ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

´ãÁó»ê¿¡ ÀÇÇÑ À§ Á¡¸· ¼Õ»ó

Gastric Mucosal damage by Bile acid

ÀúÀÚ : Á¶ÇöÈ«

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

°üµ¿¸Æ °áÂû ¹× Àç°ü·ù½Ã¿¡ ¹ß»ýÇÏ´Â ¾Ç¼ººÎÁ¤¸Æ¿¡ ´ëÇÑ ÀÚÀ²½Å°æ°èÀÇ ¿µÇâ

Influence of Autonomic Nerve System in Occlusion and Reperfusion Arrhythmia

ÀúÀÚ : À̱âÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

½ÉÀüµµ»ó ST-TÀý Àü±âÀû »óÈ£±³´ë¸Æ°ú ½É½Ç¼ººÎÁ¤¸Æ°úÀÇ °ü°è

The Relationship between ST-T electrical alternans on EKG and ventricular arrhythmia

ÀúÀÚ : ±èÀ¯È«

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

´ëÀå ¿ëÁ¾ÀÇ ³»½Ã°æÀû ¹× Á¶Á÷ÇÐÀû ¼Ò°ß

Endoscopic and Histopathologic Findings of Colon polyp

ÀúÀÚ : ±Ç¿µ¼ö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

³»½Ã°æÀû ½Äµµ Á¤¸Æ·ù °æÈ­¼úÈÄÀÇ ±ÕÇ÷Áõ¿¡ ´ëÇÑ ¿¬±¸

Bacteremia Following Endoscopic Injection Sclerotherapy of Esophageal Varices

ÀúÀÚ : ±Ç°æ¼ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

°üµ¿¸Æ °áÂû ¹× Àç°ü·ù½Ã¿¡ ¹ß»ýÇÏ´Â ¾Ç¼ººÎÁ¤¸Æ¿¡ ´ëÇÑ ¹ÌÁֽŰæÀÇ ¿µÇâ

Influence of Vagus Nerve on Coronary Occlusion and Reperfusion Arrhythmia in Cats

ÀúÀÚ : ±èÁ¾È£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1990  

ÇãÇ÷¼º ÀüÁ¶°Ç(Ischemic Preconditioning)ÀÌ Àç°ü·ù ºÎÁ¤¸Æ¿¡ ¹ÌÄ¡´Â ¿µÇâ

The Effects of Myocardial Ischemic Proconditioning on Reperfusion Arrhythmia in cat

ÀúÀÚ : À¯¿µÈÆ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1991  

»óºÎÀ§Àå°üÃâÇ÷¿¡ ´ëÇÑ ÀÓ»óÀû °íÂû

Clinical observations of upper gastrointestinal hemorrhage

ÀúÀÚ : ÃÖÁ¾È­

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1991  

ÀϽÃÀû ½É±Ù ÇãÇ÷ÀÇ Circadian Variation¿¡ °üÇÑ ¿¬±¸

Circadian variation of transient myocardial ischemia

ÀúÀÚ : ÀÌÁ¤¹Ì

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1991  

¿ÏÀü ¹æ½Ç Â÷´Ü ȯÀÚ¿¡¼­ Á¼Àº QRSÆĸ¦ °®´Â º¸Á¶Àû ½É¹Ú Á¶À²±âÀÇ Æ¯¼º

Characteristics of subsidiary pacemaker in complete heart block with narrow QRS complex

ÀúÀÚ : µµÁØ¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1991  

´ç´¢º´ ȯÀÚ¿¡¼­ Power Spectrum Analysis¸¦ ÀÌ¿ëÇÑ ÀÚÀ²½Å°æ°è ÀÌ»óÀÇ °ËÁ¤

Assessment of diabetic autonomic neuropathy by power spectrum analysis

ÀúÀÚ : À̵ÎÇÏ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1991  

´ç´¢º´¼º ½ÉÇ÷°ü°è ÀÚÀ²½Å°æº´Áõ°ú Corrected QT °£°ÝÀÇ ¿¬Àå

Corrected Q-T Interval Prolongation in Diabetic Cardic Autonomic Neuropathy

ÀúÀÚ : ¹ÚÁ¾¼±

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1991  

±Ë¾ç¼º ´ëÀå¿°ÀÇ ÀÓ»óÀû ¿¬±¸

A Clinical Study of Ulcerative Colitis

ÀúÀÚ : ÀÌ»ï¹ü

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1991  

Æó¿Ü°áÇÙÀÇ Á¶Á÷¿¡¼­ÀÇ °áÇÙ±Õ °ËÃâ

Isolation of tubercle bacilli from the extrapulmonary tuberculosis

ÀúÀÚ : ³ëÁø¿ì

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1991  

Æó ¼¼Ã´À¸·Î À¯¹ßµÈ È£ÈíºÎÀü¿¡¼­ÀÇ °íºóµµ Jet ȯ±â¹ýÀÇ È¿°ú

Effect of high frequency jet ventilation in acute respiratory failure induced by alveolar lavage in rabbits

ÀúÀÚ : ¹Ú½ÃÈ­

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1992  

°í¾çÀÌ °ü»óµ¿¸Æ Æó»ö ¹× Àç°ü·ù½Ã °íÇØ»ó ½ÅÈ£°¡»ê ½ÉÀüµµÀÇ º¯È­

Effect of Coronary Artery Occlusion and Reperfusion on High Resolution Electrocardiography in Cats

ÀúÀÚ : Á¤¹®È£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1992  

°©»ó¼±È¯ÀÚ¿¡¼­ÀÇ 5ºÐ Tc-99m Pertechnetate ¼·ÃëÀ²°ú ¹æ»ç¼º ¿Á¼Ò ¼·ÃëÀ²ÀÇ »ó°ü°ü°è

Correlation between 5-minute 99mTc-pertechnetate uptake and 24-hour I-131 uptake in patients with thyroid disease

ÀúÀÚ : ÀÌÂù¿ì

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1992  

°æ½Äµµ ½ÉÃÊÀ½Æİ˻翡 ÀÇÇÑ Á½ÉÀÌÀÇ ±â´ÉÆò°¡

Evaluation of left atrial appendage function by transesophageal echocardiography

ÀúÀÚ : °­½ÂÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1993  

³­Ä¡¼º º¹¼ö¸¦ µ¿¹ÝÇÑ °£°æº¯Áõ ȯÀÚÀÇ Ç÷Àå AldosteroneÄ¡

Plasma Aldosterone in Liver Cirrhosis with Intractable Ascites

ÀúÀÚ : ¼­Á¤ÀÏ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1993  

Àü½Å¼º È«¹Ý¼º ³¶Ã¢ÀÇ ÀÓ»ó»ó

Clinical Manifestations on Systemic Lupus Erythematosus

ÀúÀÚ : ÀüÁØÇÏ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1993  

½ÉÇ÷°ü°è ÁúȯÀÚ¿¡¼­ »óºÎ À§Àå°ü ³»½Ã°æ °Ë»çµ¿¾ÈÀÇ ½ÉÀüµµ ¹× µ¿¸ÆÇ÷ »ê¼Ò Æ÷È­µµ º¯È­

The Effect of Gastrofiberscopy on ECG and Arterial Oxygen Saturation in Patients with Cardiovascular Disease

ÀúÀÚ : ¹ÚÁøÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1993  

À§ Á¤¸Æ·ù ÃâÇ÷¿¡ ÀÀ±Þ ³»½Ã°æÀû °æÈ­¼úÀÇ Ä¡·áÈ¿°ú

Endoscopic Sclerotheraphy in Bleeding Gastric Varices

ÀúÀÚ : À庴ÀÍ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1993  

ÃÊ»ê°ú Áßź»ê³ªÆ®·ý Åõ¼®¾×À» ÀÌ¿ëÇÑ Ç÷¾× Åõ¼®ÀÇ ºñ±³ºÐ¼®

Comparative Study of Acetate and Bicarbonate Hemodialysis in Patients with Chronic Renal Failure

ÀúÀÚ : Á¤¼ºº¹

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1993  

RDW¸¦ ÀÌ¿ëÇÑ ºóÇ÷ÀÇ ÀçºÐ·ù

Modified Classification of Anemia by RDW

ÀúÀÚ : ȲÇü±â

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1993  

½ºÆ®·¹½º°¡ ½ÉÇ÷°ü°èÀÇ ÀÚÀ²½Å°æÈ°¼ºµµ¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effect of Stress on Cardiovascular Autonomic Nerve Activity in Human

ÀúÀÚ : À̱âÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1993  

½ÇÇèÀû ÇãÇ÷ ¹× Àç°ü·ùÀ¯µµ½Ã AdenosineÀÌ ½É±ÙÀç°ü·ù¼Õ»ó¿¡ ¹ÌÄ¡´Â ¿µÇâ

The Protective Effect of Intravenous Adenosine on Myocardial Reperfusion Injury in Feline Heart Model

ÀúÀÚ : ½Åµ¿±¸

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1994  

°üµ¿¸Æ ÃÔ¿µ»ó °æµµÀÇ µ¿¸Æ°æÈ­°¡ Àִ ȯÀÚ¿¡¼­ °üµ¿¸Æ³»°æÀÇ Acetylcholine°ú nitrate¿¡ ´ëÇÑ ¹ÝÀÀ

The Response of Coronary Artery Diameter to Acetylcholine and Nitrate in Patents with or without Minimally Diseased Coronary Artery

ÀúÀÚ : ¹ÚÈ­Á¾

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1994  

¹®¸Æ¾Ð Ç×ÁøÁõÀÇ Ç÷¿ªÇÐÀû Ư¼º

Hemodynamic Properties of Portal Hypertension in a Portal Vein Stenotic Rat Model

ÀúÀÚ : ±èųâ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1994  

´ç´¢º´È¯ÀÚ¿¡¼­ÀÇ ¹«Áõ»ó ¼¼±Õ´¢

Asymptomatic Bacteriuria in Patients with Diabetic Mellitus

ÀúÀÚ : ½Å°æö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1994  

¸¸¼º ½ÅºÎÀü ȯÀÚÀÇ ºóÇ÷¿¡ À־ Erythropoietin Ä¡·á¿Í °£ ±â´É¿¡ µû¸¥ Ç÷ûÁöÇ¥ÀÇ ¾ç»ó

A Study on the Serologic Parameters in Patients with Anemia of Chronic Renal Failure - According to Erythropoietin Treatment and Liver Function

ÀúÀÚ : ÀÓÁ¾½Ä

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1994  

¿îµ¿ºÎÇϽÉÀüµµ°Ë»ç¿¡ À־ ST/HR SlopeÀÇ Áø´ÜÀûÀÇÀÇ

Diagnostic Significance of ST/HR Slope of Exercise Stress Test in Coronary Artery Disease

ÀúÀÚ : ÀÌÅÂÀÏ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1994  

±Þ¼º ½É±Ù°æ»öÁõ ¹ßÇà À§ÇèÀÎÀÚ¿Í °æ»ö °ü·Ãµ¿¸ÆÀÇ ÇùÂøÁ¤µµ¿ÍÀÇ ¿¬°ü¼º

The Relation of the Risk Factors of Acute Mycardial Infarction to the Degree of Stenosis of Infarct Related Artery

ÀúÀÚ : ±è¿µÁø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1994  

´ç´¢º´È¯ÀÚ¿¡¼­ ½ÉÇ÷°ü°è ÀÚÀ²½Å°æº´Áõ°ú ¼ö¸éÁß µ¿¸ÆÇ÷ »ê¼ÒÆ÷È­µµ¿ÍÀÇ °ü°è

Arterial Oxygen Saturation during Sleep in Patients with Non Insulin Dependent Diabetes Mellitus

ÀúÀÚ : ¿ø±ÔÀå

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1994  

Æó¾Ï Áø´Ü¿¡ À־ CYFRA 21-1ÀÇ À¯¿ë¼º

Usefulness of CYFAR 21-1 in Diagnosis of Lung Cancer

ÀúÀÚ : À±Çö´ë

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1995  

°æÇÇÀû °üµ¿¸Æ ¼ºÇü¼ú½Ã dz¼± Å©±â¿Í °üµ¿¸ÆÀÇ ÇùÂø ÇüÅ°¡ Ç÷°ü ź¼º¹Ýµµ¿¡ ¹ÌÄ¡´Â ¿µÇâ

Influence of Balloon Size and Morphology of Coronary Stenosis on Elastic Recoil after Percutaneous Transluminal Coronary Angioplasty

ÀúÀÚ : ÃÖ±³¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1995  

Æó¼â¼º ±âµµ ÁúȯÀÚ¿¡¼­ ±â°üÁö È®ÀåÁ¦¿¡ ´ëÇÑ ¹ÝÀÀÀÇ Æò°¡

Interpretation of Bronchodilator Response in Patients with Obstructive Airway Disease

ÀúÀÚ : ÃÖÈñÁø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1995  

´ã³¶°á¼® ȯÀÚ¿¡¼­ ¼ö¼úÀü ³»½Ã°æÀû ¿ªÇ༺ ´ãµµ Á¶¿µ¼úÀÇ ÀûÀÀÁõ

Indications for Pre-operative RECP in Patients with Gall Bladder Stones

ÀúÀÚ : ±è±â´ö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1995  

¸¸¼º Æó¼â¼º ÆóÁúȯ ȯÀÚ¿¡¼­ ÃÖ´ë Èí±â À¯¼Ó°ú ÃÖ´ë Àڹ߼º ȯ±â·®°úÀÇ »ó°ü °ü°è

The Role of MIFR in Determining MVV in Patients with Chronic Obstructive Pulmonary Disease

ÀúÀÚ : ·ùÇå¸ð

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1995  

¸¸¼º±âµµÆó¼â ȯÀÚ¿¡¼­ ±Þ¼º È£Èí ºÎÀü½Ã BiPAPÀÇ È¿°ú

The Effect of Nasal Bi-PAP Ventilation in Acute Exacerbation of Chronic Obstructive Airway Disease

ÀúÀÚ : Á¶¿µº¹

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1996  

»êÈ­Áú¼Ò ¾ïÁ¦Á¦°¡ ¹®¸Æ °íÇ÷¾Ð ÁãÀÇ °úÇ÷·ù ¼øȯ¿¡ ¹ÌÄ¡´Â È¿°ú

Effect of Nitric Oxide Inhibitor on Hyperdynamic Circulation in Portal Hypertensive Rats

ÀúÀÚ : À庴ÀÍ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1996  

Recombinant human erythropoietin¿¡ ºÎÀûÀýÇÑ ¹ÝÀÀÀ» º¸ÀÌ´Â ¸¸¼º ½ÅºÎÀü¼º ºóÇ÷¿¡ ´ëÇÑ DesferrioxamineÀÇ È¿°ú

The Effect of Desferrioxamine on Anemia of Chronic Renal Failure-Cases to Inappropriate Response under Recombinant Human Eythropoietin Treatment

ÀúÀÚ : °­È£Á¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1996  

ÆóÀÇ ¾ç¼º ¹× ¾Ç¼º º´º¯¿¡¼­ Tc-99m Methoxyisobutylisonitrile lung SPECTÀÇ Áø´ÜÀû °¡Ä¡

Usefulness of Tc-99m MIBI Lung SPECT in Benign and Malignant Lesion of the Lungs

ÀúÀÚ : ±è¼º¼÷

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1996  

»êÈ­Áú¼Ò ¾ïÁ¦Á¦°¡ ¹®¸Æ °íÇ÷¾Ð ÁãÀÇ Ç÷¿ªÇÐ º¯È­¿¡ ¹ÌÄ¡´Â ¿µÇâ

ÀÚüÁ¦ÀÛ¿ø¹®

The Effects of Nitric Oxide Inhibitor on Hyperdynamic Circulation in Portal Hypertensive Rats

ÀúÀÚ : ±èÇÊ¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1997  

¸¸¼º ¹Ì¶õ¼º À§¿°°ú Helicobacter pylori¿¡ °üÇÑ ¿¬±¸

ÀÚüÁ¦ÀÛ¿ø¹®

Study for Relationship between Chronic Erosive Gastritis and Helicobacter pylori

ÀúÀÚ : ¹ÚÂù¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1997  

Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ ½ÉÇ÷°ü°è ÀÚÀ²½Å°æº´Áõ°ú ¸Á¸·º´Áõ°úÀÇ °ü°è

ÀÚüÁ¦ÀÛ¿ø¹®

Relationship between Cardiovascular Autonomic Neuropathy and Diabetic Retinopathy in Patients with Non-Insulin Dependent Diabetes Mellitus

ÀúÀÚ : ÀÌÀçÃá

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1997  

¸¸¼º BÇü °£Áúȯ¿¡¼­ °£¿° B Virus Ç¥½ÄÀÚ ¹ßÇö¿¡ µû¸¥ DNAÀÇ °ËÃâ

ÀÚüÁ¦ÀÛ¿ø¹®

Detection of Serum Hepatitis B Virus DNA According to HBV Markers in Chronic Hepatitis B Liver Disease

ÀúÀÚ : À̵¿ÁØ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1997  

Thioacetamide À¯¹ß ±Þ¼º °£¼Õ»ó¿¡¼­ Diphenyl dimethyl dicarboxylate Åõ¿© ÈÄ Ç÷û transaminase È°¼ºµµÄ¡ °¨¼ÒÈ¿°ú

ÀÚüÁ¦ÀÛ¿ø¹®

The Decreasing Effect of Diphenyl Dimethyl Dicarboxylate for Elevated Serum Transaminase Activity on Thioacetamide Treated Acute Hepatic Injury

ÀúÀÚ : ¼­Á¤ÀÏ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1997  

ÇãÇ÷¼ºÀüÁ¶°ÇÀÇ ½É±Ùº¸È£ÀÛ¿ë¿¡¼­ Protein kinase C ¹× Heat shock proteinÀÇ ¿ªÇÒ

ÀÚüÁ¦ÀÛ¿ø¹®

The Role of Protein Kinase C and Heat Shock Protein on Cardioprotective Effects of Ischemic Preconditioning in Cats

ÀúÀÚ : °í¸í±¸

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1997  

Ç÷°ü³»ÇǼ¼Æ÷¿¡¼­ Æ÷µµ´ç¿¡ ÀÇÇÑ Aldose reductase mRNA ¹ßÇö

ÀÚüÁ¦ÀÛ¿ø¹®

The Effects of Glucose on Aldose Reductase mRNA Expression in CPAE Cells

ÀúÀÚ : ÀÌÂù¿ì

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1997  

ÇãÇ÷¼º ÀüÁ¶°ÇÀÇ ½Éº¸È£ÀÛ¿ë ±âÀü¿¡¼­ KATP Åë·Î È°¼ºÈ­¿Í ´Ü»ó¼º È°µ¿Àü¾Ð±âÀÇ º¯È­

The Myocardial protective Role of KATP Channel activation and Monophasic Action Potential Duration Shortening by inschemic Preconditioning in Cats

ÀúÀÚ : ¹ÚÁ¾¼±

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1998  

¼ö¸é ¹«È£Èí ÁõÈıº¿¡¼­ÀÇ ÀÚÀ²½Å°æÀå¾Ö

Autonmic Neuropaty in Sleep Apnea Syndrome

ÀúÀÚ : ÀÌÇÐÁØ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1998  

½Å À̽ÄÈÄ Åð¿ø½Ã Ç÷ûũ·¹¾ÆƼ´Ñ Ä¡¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ºñ¸é¿ªÇÐÀûÁ¶°Ç

Nonimmunological Factors Influencing Serum Creatinine on Discharge after Kidney Transplantation

ÀúÀÚ : ÀÓ»ó¿ì

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1998  

Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ ½ÉÇ÷°ü°è ÀÚÀ²½Å°æº´Áõ°ú QT dispersion°úÀÇ »ó°ü°ü°è

The Relation of QTc dispersion and Cardiovascular Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus

ÀúÀÚ : À±Áö¼º

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1998  

º¹¸·ÆòÇü°Ë»ç¿¡ ¿µÇâÀ» ÁÖ´Â ÀÎÀںм®

An Analysis of The Factors InFluencing PET results

ÀúÀÚ : Á¤Ç×Àç

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1999  

Á¦2Çü ´ç´¢º´ ȯÀÚÀÇ ½½°ñ°üÀý¿°¿¡¼­ °ñÁõ½Äü Çü¼ºÀÇ ÀúÇÏ

Impairment of Osteophyte Formation in Patients with Type 2 Diabetes Mellitus and Knee Osteoarthritis

ÀúÀÚ : ±èºÀÁØ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1999  

ÀÀ±ÞÀÇ·á¼¾ÅÍ¿¡ ³»¿øÇÑ ºñ¿Ü»ó¼º ÈäÅëȯÀÚÀÇ ÀÓ»ó¾ç»ó

Clinical Presentation of the Patients with Non-Traumatic Chest Pain in Emergency Department

ÀúÀÚ : Á¤ÁØ¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1999  

ÁÂ½É½Ç À̿ϱâ´ÉÀÇ Æò°¡¿¡ À־ µµÇ÷¯Á¶Á÷¿µ»óÀ» ÀÌ¿ëÇÑ ½Â¸ðÆÇ·û ¼ÓµµÀÇ À¯¿ë¼º

Usefulness of Mitral Annular Velocity for Evaluation of Left Ventricular Diastolic Function

ÀúÀÚ : È«±×·ç

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1999  

¸¸¼º Æó¼â¼º ÆóÁúȯ ȯÀÚ¿¡¼­ ÃÖ´ë ¿îµ¿½Ã¿Í ¼ö¸é½ÃÀÇ »ê¼Ò Æ÷È­µµÀÇ ºñ±³

Sleep and Exercise Related Oxygen Desaturation in Patients with Chronic Obstructive Pulmonary Disease

ÀúÀÚ : ½ÅâÁø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1999  

»óºÎÀ§Àå°ü ÃâÇ÷ ¿øÀÎÀÇ º¯È­¾ç»ó

The Change of Causes of Upper Gastrointestinal Bleeding

ÀúÀÚ : ±èÇöÁ¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1999  

¼ö¸é¹«È£ÈíÁõÀÇ ÁßÁõµµ¿Í ¾ÈÁ¤½Ã ¿¡³ÊÁö´ë»ç ¹× Ç÷Áß Leptin°úÀÇ °ü°è

The Relationship of the Severity of Sleep Apnea Syndrome to the Resting Energy Expenditure and Leptin

ÀúÀÚ : ¾ÈÀçÈñ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1999  

ÇãÇ÷¼º ÀüÁ¶°Ç¿¡¼­ Adenosine ¼ö¿ëü, Protein Kinase C ¹× KATPÅë·Î¿¡ ÀÇÇÑ ½É±Ùº¸È£È¿°ú¿Í ´Ü»ó¼º È°µ¿Àü¾Ð±âÀÇ º¯È­

The Myocardial Protective Effect and Change of the Monophasic Action Potential Duration by Adenosine Receptor, Protein Kinase C and KATP Channel in Ischemic Preconditioning in the Cat Heart

ÀúÀÚ : ±èÀ¯È«

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1999  

ºñ½ºÅ×·ÎÀ̵强 Ç׿°Áõ Á¦Á¦¿¡ ÀÇÇÑ ±Þ¼º À§Á¡¸· ¼Õ»ó±âÀü

The Role of Neutrophil on Indomethacin induced Acute Gastric Mucosal Injury

ÀúÀÚ : À±ºÀ¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 1999  

¸»ÃÊÇ÷¾× Á¶Ç÷¸ð¼¼Æ÷ äÁý½Ã±â¸¦ °áÁ¤Çϱâ À§ÇÑ ¿¹ÃøÁöÇ¥ÀÇ Æò°¡

Parameters to Predict the Adequate Collection of Peripheral Blood Progenitor Cells

ÀúÀÚ : ±èº´´ö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 1999  

Vascular Endothelial Growth Factor¿¡ ÀÇÇÑ Ç÷°ü ³»ÇǼ¼Æ÷ÀÇ Áõ½ÄÀÛ¿ë¿¡ À־ eNOSÀÇ ¹ßÇö±âÀü

Expression and Regulation of Endothelial Growth Factor Oxide Synthase by Vascular Endothelial Growth Factor in Endothelial Cell Proliferation

ÀúÀÚ : ¹ÚÈ­Á¾

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2000  

Interleukin-1¥â¿¡ ³ëÃâµÈ ÈòÁã ÃéÀå¼ÒµµÀÇ nitricoxide»ý¼º, Àν¶¸° ºÐºñ ¹× heat shock protein 70 ¹ßÇö¿¡ ¹ÌÄ¡´Â aminoguanidineÈ¿°ú

Effects of aminoguanidine on nitric oxide production, insulin release and hsp 70 expression in cultured rat islets exposed th IL-1¥â

ÀúÀÚ : ÀαÔÀå

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2000  

°áüÁ¶Á÷ Áúȯ¿¡¼­ÀÇ 99m£ÞTc-DTPA ¿¬¹«½ºÄµÀ» ÀÌ¿ëÇÑ ÆóÆ÷-¸ð¼¼Ç÷°ü Åõ°ú¼ºÀÇ Æò°¡

Evaluation of lung permeability in patients with connective tissue disease using 99m Tc-DTPA aerosol scintigraphy

ÀúÀÚ : È«¿µÈÆ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

·ù¸¶Æ¼½º °üÀý¿° ȯÀÚ¿¡¼­ÀÇ ÀÚÀ²½Å°æ ±â´ÉÀå¾Ö

Autonomic Nervous System Dysfunction in Patients with Rheumatoid Arthritis

ÀúÀÚ : ÀÌÀº¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

ºñ¼Ò¼¼Æ÷¼º Æó¾Ï¿¡¼­ Ç÷û ¹× Á¶Á÷ÀÇ c-erbB-2 Á¾¾ç ´Ü¹éÀÇ ¹ßÇöÀ²°ú »ó°ü°ü°è

C-erbB-2 Protein Expression and Correlation in Sera and Tumors of Non-Small Lung Cancer Patients

ÀúÀÚ : ÀÌ»ó¿±

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

Çѱ¹Àο¡ À־ ´ëÀåÀÇ ÀÛÀº ¿ëÁ¾ÀÇ ÀÇÀÇ

The Significance of Small Polyp in Koreans

ÀúÀÚ : ±Ç¼ø¿í

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

¹é¼­¿¡¼­ ÃâÇ÷¼º ¼ïÀÌ Àå³» ¼¼±Õ ÀüÀ§¿¡ ¹ÌÄ¡´Â ¿µÇâ

Bacterial translocation in experimental hemorrhagic shock in rats

ÀúÀÚ : Á¤¼ºº¹

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2000  

°áÇÙ¼º ÀÓÆļ±¿°ÀÇ ÀÓ»óÀû °íÂû

A Clinical Study of Tuberculous Lymphadenitis

ÀúÀÚ : ¹ÚÇýÁ¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

°í ÇÁ·Î¶ôƾÇ÷ÁõÀÇ ÀÓ»óÀû °íÂû

A clinical review on hyperprolactinemia

ÀúÀÚ : ¹ÚÁøö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

´ëÀå ³»½Ã°æÀ» ÀÌ¿ëÇÑ ¿ëÁ¾ ÀýÁ¦¼úÀÇ ÇÕº´Áõ

Complication of colonoscopic polypectomy

ÀúÀÚ : ±è¿µ¼º

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2000  

±Þ¼º´ã°ü¼º ÃéÀå¿°¿¡¼­ ´ã°ü°á¼®ÀÇ ¿¹ÃøÀÎÀÚ

ÀúÀÚ : ÃÖ¼±ÅÃ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

Èí¿¬½À°ü¿¡ µû¸¥ Æó¾Ï¹ß»ý °¨¼ö¼º¿¡ ´ëÇÑ ¼ºº°ÀÇ Â÷ÀÌ

ÀúÀÚ : ÃÖÃæ°æ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

Á¶Ç÷¸ð¼¼Æ÷ÀÇ Ã¼¿ÜÈ®Àå°ú AmifostineÀÌ ¹ÌÄ¡´Â ¿µÇâ

Ex Vivo Expansion of Hematopoietic Stem Cells and Amifostine Effects

ÀúÀÚ : ·ùÇå¸ð

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2001  

Á¦´ëÇ÷ Á¶Ç÷¸ð¼¼Æ÷ÀÇ Ã¼¿ÜÈ®Àå¿¡ ³Ãµ¿º¸Á¸ÀÌ ¹ÌÄ¡´Â ¿µÇâ

ÀúÀÚ : ÃÖÀçÇõ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

Á¶±â À§¾ÏÀÇ ³»½Ã°æÀû Ä¡·á È¿°ú

ÀúÀÚ : ÃÖÁø¼ö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

½Å ÀÌ½Ä È¯ÀÚÀÇ ÇÕº´Áõ¿¡ ´ëÇÑ ¿¬±¸

ÀúÀÚ : Á¶±ÔÇâ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

¿µ³²´ëÇк´¿ø¿¡¼­ °£¼¼Æ÷¾ÏÀ¸·Î Áø´ÜµÈ 1760¸íÀÇ ÀÓ»óºÐ¼®

ÀúÀÚ : ÀºÁ¾·Ä

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

¸¸¼ºÆó¼â¼ºÆóÁúȯ¿¡¼­ Á¦Áö¹æ(Fat-free Mass)¿¡ µû¸¥ ½É¡¤Æó±â´ÉÀÇ Â÷ÀÌ

ÀúÀÚ : ¹®¿µÃ¶

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

°æ±¸ Ç÷´ç °­ÇÏÁ¦¿¡ ÀÌÂ÷¼º ½ÇÆи¦ º¸ÀÎ Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ÀÇ ICA¿Í GADÇ×üÀÇ ÀÇÀÇ

ÀúÀÚ : ¿ÀÁ¤Çö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2001  

À§¾Ï¿¡¼­ c-met Á¾¾ç´Ü¹é °ú¹ßÇöÀÇ ¸é¿ªÁ¶Á÷È­ÇÐÀû Æò°¡

ÀúÀÚ : ¿ÀÇö¾Æ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2002  

PÆÄ ½ÅÈ£ °¡»ê Æò±Õ ½ÉÀüµµ¹ýÀ» ÀÌ¿ëÇÑ ¹ßÀÛ¼º ½É¹æ ¼¼µ¿ÀÇ ¹ß»ý À§Çèµµ ¿¹Ãø ¿©°ú PÆÄ ºÐ»êÃøÁ¤ÀÇ Áø´ÜÀû À¯¿ë¼º

ÀúÀÚ : ±è ¿õ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2002  

Àü½Å¼º È«¹Ý¼º ³¶Ã¢ ȯÀÚ¿¡¼­ÀÇ ÀÚÀ² ½Å°æ°è ±â´ÉÀå¾Ö

ÀúÀÚ : ±è¼ºµ¿

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2002  

ÀÌ½Ä ÈÄ 12°³¿ùÀÌ Áö³­ ½Å À̽ÄȯÀÚ¿¡¼­ÀÇ Cyclosporine trough level(CO)°ú 2-hour postdose blood level(C2) »çÀÌÀÇ »ó°ü °ü°è ¹× ÀûÁ¤ C2 level

ÀúÀÚ : ±èÁ¤¹Ì

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2002  

Á¤»óÇ÷¾ÐÀ» °¡Áø Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ Ç÷¾ÐÀÇ ÀÏÁß º¯µ¿ ÀÌ»ó¿¡ ¿µÇâÀ» ÁÖ´Â ÀÎÀÚ

»ó¼¼º¸±â

Factors Determining Circadian Blood Pressure Rhythm in Normotensive Patients with Type 2 Diabetes

ÀúÀÚ : ±èÀçÈ«

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2002  

¼ÒÈ­¼º±Ë¾ç ÃâÇ÷ ȯÀÚ¿¡¼­ ³»½Ã°æÀû Ä¡·á ÈÄ 2Â÷ Ã߽à ³»½Ã°æ°Ë»ç´Â ²À ÇÊ¿äÇÑ°¡?

»ó¼¼º¸±â

Is Second-Look Endoscopy Usefull for All Bleeding Peptic Ulcers

ÀúÀÚ : ÀÌÀºÁÖ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2002  

Ç︮ÄÚ¹ÚÅÍ ¾ç¼ºÀÎ ¼ÒÈ­¼º ±Ë¾ç ȯÀÚ¿¡¼­ Ç︮ÄÚ¹ÚÅÍ ¹Ú¸ê ¿ä¹ý¿¡ ÀÇÇÑ ±Ë¾ç Ä¡·á È¿°ú

ÀúÀÚ : ÀÌ»ó¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2002  

ÁøÇ༺ ºñ¼Ò¼¼Æ÷¼º Æó¾Ï ȯÀÚ¿¡¼­ Docetaxel°ú Cisplatin º¹ÇÕÈ­Çпä¹ýÀÇ È¿°ú

»ó¼¼º¸±â

Effect of Combination Chemotherapy with Docetaxel plus Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

ÀúÀÚ : °­ÈñÁ¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2003  

º¹¸·Åõ¼® ȯÀÚ¿¡¼­ ÀÎü ±¸¼º ¼ººÐÀÇ º¯È­¿Í ÀÌ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿ä¼Ò

»ó¼¼º¸±â

The Changes of the Body Composition and the Affected Factors in Continuous Ambulatory Peritoneal Dialysis (CAPD) patients

ÀúÀÚ : ±èµ¿ÇÑ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2003  

½É½Ç¼¼µ¿ÀÇ À¯¹ß±âÀü¿¡ À־ ½É½ÇÀÇ Àü±âÀû »óȯÇö»ó°ú ½É½Ç¼¼µ¿ À¯¹ß ¿ªÄ¡¿¡ ´ëÇÑ ÀÚÀ²½Å°æ°èÀÇ ¿µÇâ

»ó¼¼º¸±â

Effects of Direct Sympathetic and Vagal Stimulation on Electrical Restitution and Ventricular Fibrillation Threshold

ÀúÀÚ : È«±×·ç

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2003  

¸¸¼º±â°üÁö¿°°ú Æó±âÁ¾È¯ÀÚ¿¡¼­ üÁß°¨¼Ò¿Í Ç÷Áß Leptin ¹× TNF-¥á¿ÍÀÇ »ó°ü°ü°è

»ó¼¼º¸±â

Correlation between Serum Leptin, Plasma TNF-a and Weight Loss in Patients with Chronic Bronchitis and Emphysema

ÀúÀÚ : ¹éÁ¾ÇØ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2003  

Á¦1Çü ´ç´¢º´ ȯ¾Æ¿¡¼­ ÃéÀå ¼Òµµ ¼¼Æ÷Áú Ç×ü¿Í GAD Ç×üÀÇ 5³â ÃßÀû°Ë»ç

»ó¼¼º¸±â

Clinical Time-course and Titers of ICAs and GADA in Childhood onset Type 1 DM

ÀúÀÚ : À̽ÃÇü

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2003  

¸¸¼ºÆó¼â¼ºÆóÁúȯ¿¡¼­ üÁß°¨¼Ò¿Í TNF-¥á, sTNF-R55, sTNF-R75 ¹× leptin°úÀÇ °ü°è

»ó¼¼º¸±â

The Relationship between Weight Loss and TNF-alpha, sTNF-R55, sTNF-R75 and Leptin in Patients with Chronic Obstructive Pulmonary Disease

ÀúÀÚ : ½Å°æö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2003  

À§¾Ï Á¶Á÷¿¡¼­ uPAR, IL-8 À¯ÀüÀÚ ¹ßÇö°ú ÀÓ»óº´¸®ÇÐÀû ¼Ò°ßÀÇ »ó°ü°ü°è

»ó¼¼º¸±â

Relationship between uPAR, IL-8 Gene Expression and Clinico-Pathologic Features of Gastric Cancer

ÀúÀÚ : ÀÌ»ó¿±

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2003  

¹ßÀÛ¼º ½É¹æ ¼¼µ¿¿¡¼­ ½É¹Ú º¯À̵µÀÇ º¯È­

»ó¼¼º¸±â

Heart rate variability changes before the onset of paroxysmal atrial fibrillation

ÀúÀÚ : ±è¹Î°æ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2003  

½ÅüÁú·®Áö¼ö, üÁö¹æÀ² ¹× Á¦Áö¹æÁú·®Áö¼ö°¡ ³ë·Â¼º È£±â°î¼±¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

The Effects of Body Mass Index, Fat Percentage, and Fat Free Mass Index on Forced Expiratory Volume Curve

ÀúÀÚ : ¹ÚÁö¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2003  

Àΰ£ ¿¬°ñ ¼¼Æ÷ÁÖ HTB94¿¡¼­ cDNA chip technology¸¦ ÀÌ¿ëÇÑ interferon-1¥â-responsive genesÀÇ ¹ßÇö ¾ç»ó

»ó¼¼º¸±â

Identification of interleukin-1b-responsive genes in human chondrocyte HTB94 cells by cDNA chip technology

ÀúÀÚ : ÀüÁØÇÏ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2004  

±¹¼ÒÁøÇ༺ ºñ¼Ò¼¼Æ÷Æó¾Ï ȯÀÚ¿¡¼­ Weekly PaclitaxelÀ» ÀÌ¿ëÇÑ È­ÇÐ ¹æ»ç¼± µ¿½Ã¿ä¹ýÀÇ È¿°ú

»ó¼¼º¸±â

Efficacy of Weekly Paclitaxel and Concurrent Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.

ÀúÀÚ : ¹è¼ºÈ­

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2004  

Æó¾ÏÁ¶Á÷¿¡¼­ common MAGE RT-PCRÀ» ÀÌ¿ëÇÑ Melanoma antigen-encoding geneÀÇ ¹ßÇö

»ó¼¼º¸±â

Expression of Melanoma Antigen-Encoding Genes by Common MAGE RT-PCR in Lung Cancer Tissues

ÀúÀÚ : ½ÅâÁø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2004  

Ä¡·áÁßÀÎ Àü½Å¼º È«¹Ý¼º ·çǪ½º ȯÀÚ¿¡¼­ÀÇ ÁöÁú´ë»ç º¯È­

»ó¼¼º¸±â

Lipid Profiles in the patients with Systemic Lupus Erythematosus

ÀúÀÚ : ÀÌÁ¤ÈÆ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2004  

´ç´¢º´¼º Á·ºÎ±Ë¾çÀÇ Ä¡·á¿Í Àý´Ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÎÀÚ

»ó¼¼º¸±â

Poor Prognosis Factors and Risk Factors of Amputation in Diabetic Foot Ulcer

ÀúÀÚ : Àº¹ÌÁ¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2004  

´ëÀå »ùÁ¾ÀÇ À°¾ÈÀû ÇüÅ¿¡ µû¸¥ ¥â-catenin, bcl-2, p53 ¹× COX-2ÀÇ ¸é¿ªÁ¶Á÷È­ÇÐÀû ¹ßÇö

»ó¼¼º¸±â

Immunohistochemical Expression of ¥â-catenin, p53, bcl-2 and COX-2 (cyclooxygenase-2) According to Macroscopic Morphology of Colorectal Adenomas

ÀúÀÚ : ±è¿µ¼º

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2004  

Á¦´ëÇ÷ ü¿Ü¹è¾ç½Ã È¿°úÀûÀÎ B ¸²ÇÁ±¸ÀÇ ¸é¿ªÀ籸¼º

»ó¼¼º¸±â

Effective B lymphocyte-mediated immune reconstitution on ex vivo expansion of human cord blood

ÀúÀÚ : ¹®¿µÃ¶

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2004  

±¹¼ÒÁøÇà½Äµµ¾ÏÀÇ Ç×¾ÏÁ¦ ¹× ¹æ»ç¼± º´¿ëÄ¡·á¿¡¼­ Ãß°¡ ¿Â¿­ Ä¡·áÀÇ È¿°ú

»ó¼¼º¸±â

Effects of Chemoradiotherapy with Hyperthermia Treatment in Locally Advanced Esophageal Cancer

ÀúÀÚ : ±è¿ë±æ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2005  

¶ó¹ÌºÎµò Ä¡·á Áß ¹ÙÀÌ·¯½º µ¹ÆÄ Çö»óÀ» º¸Àθ¸¼º BÇü °£¿° ȯÀÚ¿¡¼­ HBV ÁßÇÕÈ¿¼ÒÀÇ µ¹¿¬º¯ÀÌ ¾ç»ó

»ó¼¼º¸±â

Patterns of HBV Polymerase Mutant Analysis in Chronic Hepatitis B Patients with Viral Breakthrough during Lamivudine Treatment

ÀúÀÚ : ÃÖÀç¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2005  

º¹¸·Åõ¼® ȯÀÚ¿¡¼­ üÁö¹æÀÇ º¯È­°¡ Åõ¼®¾×/Ç÷Áß ·¾Æ¾¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

Effects of increased Fat Mass on Dialysate/Serum Leptin in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients with time on PD

ÀúÀÚ : À̽ÂÇö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2005  

°£ÈíÃæÁõÀÇ ÀÓ»ó ¾ç»ó

»ó¼¼º¸±â

Clinical Features of Clonorchiasis

ÀúÀÚ : ±è±¹Çö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2005  

SLEȯÀÚ¿¡¼­ ½ÉÇ÷°ü°è À§ÇèÀÎÀÚ IMTÀÇ À¯¿ë¼º

»ó¼¼º¸±â

Usefulness of IMT as Cardiovascular Risk Factor in Patient with SLE

ÀúÀÚ : ±Çâ¸ð

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2005  

°íÇü¾Ï¿¡¼­ ¹ß»ýÇÑ ³ú¼ö¸·¾ÏÁ¾ÁõÀÇ ÀÓ»ó ¾ç»ó°ú ¿¹ÈÄ ÀÎÀÚ

»ó¼¼º¸±â

Clinical Manifestation and Prognostic Factors of Cytologically Confirmed Leptomeningeal Carcinomatosis in Solid Tumors

ÀúÀÚ : ÀÌÀç·Ã

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2005  

Åé´Ï»ùÁ¾¿¡¼­ ¥â-catenin, hMLH1, p53, Bcl-2 ¹× COX-2ÀÇ ¹ßÇö

»ó¼¼º¸±â

Expression of ¥â-catenin, hMLH1, p53, Bcl-2 and COX-2 in Serrated Adenomas

ÀúÀÚ : ÃÖ±³¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2005  

Framingham °ü»óµ¿¸Æ À§Çè Á¡¼ö¿Í C-¹ÝÀÀ¼º ´Ü¹éÀÇ ¿¬°ü¼º

»ó¼¼º¸±â

Correlations of C-reactive protein levels and Framingham coronary risk score

ÀúÀÚ : ¼®ÁØÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2005  

´ëÀå¾Ï¿¡¼­ Cdx2 À¯ÀüÀÚ ¹ßÇöÀÇ ÀÇÀÇ

»ó¼¼º¸±â

Expression of Cdx2 Gene in Colorectal Cancer

ÀúÀÚ : ±èºÀÁØ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2005  

Æó¾ÏȯÀÚÀÇ À¯µµ°´´ã¿¡¼­ °øÅëÈæ»öÁ¾Á¾¾çÇ׿øÀÇ ¹ßÇö

»ó¼¼º¸±â

Expression of Melanoma Antigen-Encoding Genes in Induced Sputum in Patients of Lung Cancer

ÀúÀÚ : ÃÖÃæ°æ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2005  

5-FU ½ÇÆÐ ÀÌÈÄ ÀüÀ̼º À§¾Ï¿¡ ´ëÇÑ Docetaxel°ú CisplatinÀÇ º´Çà¿ä¹ýÀÇ È¿´É

»ó¼¼º¸±â

The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for The Treatment of Advanced Gastric Cancer after Failing to 5-FU based Chemotherapy

ÀúÀÚ : ½Å»óÁØ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2005  

Á¦2Çü ´ç´¢º´È¯ÀÚ¿¡°Ô¼­ °ü»óµ¿¸ÆÁúȯ ¿¹ÃøÀÎÀڷμ­ °ü»óµ¿¸Æ ¼®È¸È­Áö¼ö ÃøÁ¤ÀÇ À¯¿ë¼º

»ó¼¼º¸±â

Coronary Calcium Score to Predict Coronary Artery Disease in Patients with Type 2 Diabetes

ÀúÀÚ : ÀÌÁöÀº

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2006  

Æó ¿Ü ¼Ò¼¼Æ÷¾ÏÀÇ ÀÓ»óÀû Ư¡°ú ¿¹ÈÄ ÀÎÀÚ ºÐ¼®

»ó¼¼º¸±â

Clicinical Characteristics and Analysis of Prognostic factors of Extrapulmonary Small Cell Carcinoma

ÀúÀÚ : ±è°æ¿Á

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2006  

´ë½Ä¼¼Æ÷¿¡¼­ ºÐºñ¼º ÀÎÁöÁú °¡¼öºÐÇØ È¿¼Ò, Phospholipase A©üÀÇ ¼¼Æ÷»ç¸ê±âÀü

»ó¼¼º¸±â

The mechanism of Apoptosis by Phospholipase A2 in Macrophages

ÀúÀÚ : ÀÌÅÂÀÏ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2006  

³»½Ã°æÀû ´ã°ü´ã¼® Á¦°Å¼ú ÈÄ ´ã°ü´ã¼® Àç¹ßÀÇ À§ÇèÀÎÀÚ

»ó¼¼º¸±â

Risk factors of recurrent common duct stone

ÀúÀÚ : ÀÌÁöÀº

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2006  

Á÷Àå¾Ï¿¡¼­ ½Åº¸°­ È­Çйæ»ç¼±¿ä¹ýÀÇ ¹ÝÀÀµµ¿¡ µû¸¥ p53, Bcl-2, MGMT, p16, Ki67, GSTP ¹× BaxÀÇ ¹ßÇö

»ó¼¼º¸±â

The Expression of P53, Bcl-2, MGMT, P16, Ki67, GSTP and Bax on Response of Neoadjuvant Chemoradiotherapy in Rectal Cancer

ÀúÀÚ : ÀÌÇÐÁØ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2006  

Çѱ¹ÀÎ ½É±Ù°æ»ö ȯÀÚ¿¡¼­ ½ÉÀå µ¹¿¬»ç¸¦ ¿¹ÃøÇϱâ À§ÇÑ ºñħ½ÀÀûÀÎ À§Ç迹ÃøÀÎÀÚ ¹× MADIT ¥± CriteriaÀÇ À¯¿ë¼º

»ó¼¼º¸±â

MADIT II Criteria and Other Non-invasive Parameters for Predicting Sudden Cardiac Death in Korean Post Myocardial Infarction Patients

ÀúÀÚ : ¼ÕÀå¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2006  

Àΰ£ À§¾Ï ¼¼Æ÷ÁÖ¿¡¼­ ÇÁ·ÎÅ×¾ÆÁ» ¾ïÁ¦Á¦, º¸Å×Á¶¹ÓÀÇ Ç×¾ÏÈ¿°ú

»ó¼¼º¸±â

Anti-tumor Effects of a Proteasome Inhibitor, Bortezomib in Human Gastric Cancer Cell Lines

ÀúÀÚ : ¹è¼ºÈ­

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2007  

Àú»ê¼Ò À¯µµ INS-1 ¼¼Æ÷ »ç¸ê¿¡¼­ÀÇ NF-¥êB ¿ªÇÒ

»ó¼¼º¸±â

The Role of NF-¥êB on Hypoxia Induced Apoptosis in INS-1 Cells

ÀúÀÚ : À±Çö´ë

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2007  

°ü»óµ¿¸ÆÁúȯÀÚ¿¡¼­ µ¿¸Æ°æÈ­ÁõÀÇ ÁøÇà°ú ¿°Áõ Ç¥ÁöÀÚÀÇ »ó°ü°ü°è

»ó¼¼º¸±â

Correlation between Inflammatory Markers and Progression of Atherosclerosis in Pationts with Coronary Artery Disease

ÀúÀÚ : ¹èÁØÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2007  

°í¸³¼º Æó°áÀýÀÇ ¾Ç¼º °¨º°¿¡¼­ Dynamic CT¿Í 18F-FDG PETÀÇ À¯¿ë¼º

»ó¼¼º¸±â

The Usefulness of Dynamic CT and 18F-FDG PET to distinguish between Benignancy and Malignancy in Solitary Pulmonary Nodule

ÀúÀÚ : ¹Ú¿øÁ¾

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2007  

Á¦1Çü ´ç´¢º´ ȯÀÚ¿¡°Ô¼­ GAD ÀÚ°¡ Ç×ü¿Í ´ç´¢º´¼º ¸Á¸·º´Áõ

»ó¼¼º¸±â

GAD autoantibody and disbetic retinopathy in patients with type1 DM

ÀúÀÚ : ¹®¼±Áß

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2007  

PET/CT¿µ»ó¿¡¼­ °üÀý¿¡¼­ÀÇ 18F-FDG ¼·Ãë ¾ç»ó°ú °ñ°üÀý¿°

»ó¼¼º¸±â

18F-FDG uptake to joints on PET/CT and osteoarthritis

ÀúÀÚ : ±èÇöµµ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2007  

È®À强 ½É±Ùº´Áõ ȯÀÚ¿¡¼­ 123I-MIBG ½ºÄµÀ» ÀÌ¿ëÇÑ ¾Ç¼º ½É½Ç¼º ºó¸ÆÀÇ ¿¹Ãø

»ó¼¼º¸±â

The Significance of Cardiac Sympathetic Nerve Imaging with 123I-metaiodobenzylguanidine for Predicating the Occurrence of Ventricular Tachyarrhythmias in Patients with Idiopathic Dilated Cardiomyopathy

ÀúÀÚ : ±èµ¿Èñ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2007  

ºÐºñ¼º ÀÎÁöÁú °¡¼öºÐÇØ È¿¼Ò¿¡ ÀÇÇÑ vascular endothelial growth factor »ý¼ºÁ¶Àý

»ó¼¼º¸±â

Regulation of Vascular Endothelial Growth Factor Production by Secretory Phospholipase A2

ÀúÀÚ : Á¤Ç×Àç

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2007  

HBeÇ׿ø ¾ç¼º ¸¸¼º °£Áúȯ ȯÀÚ¿¡¼­ ¶ó¹ÌºÎµòÀÇ Àå±â Ä¡·á È¿°ú

»ó¼¼º¸±â

Long-term outcome of lamivudine therapy in the patients with HBeAg positive chronic liver disease

ÀúÀÚ : ¹®ÈñÁ¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

Áö¼Ó¼ºÅë¿øº¹¸·Åõ¼® ȯÀÚÀÇ Ã¼Áö¹æ ÃàÀû°ú Æ÷µµ´ç ¹× Icodextrin Åõ¼®¾×°úÀÇ ¿¬°ü¼º

»ó¼¼º¸±â

Fat accumulation over Time in Continuous Ambulatory Peritoneal Dialysis(CAPD) Patients and the Effect of Glucose and Icodextrin Dialysate

ÀúÀÚ : Á¶±ÔÇâ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2008  

Ç÷¾×ÇÐÀûÀÎ °Ë»çÀÇ ÀÌ»óÀ¸·Î ÇùÁøÀÌ ÀǷڵǾú´ø ÀÔ¿øȯÀÚÀÇ Æ¯Â¡ ºÐ¼®

»ó¼¼º¸±â

Inpatient consultations to hematology department over one-year period

ÀúÀÚ : ÀÌÇÏ¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

µ¿¼º ¼­¸Æ ȯÀÚ¿¡¼­ º¯È­µÈ ½ÉÀå ¹Úµ¿¼ö ¿ªÇп¡ ÀÇÇÑ µ¿°áÀý

»ó¼¼º¸±â

Altered Heart Rate Dynamics Predicts The Development of Sinus Node Dysfunction in Patients with Sinus Bradycardia: Role of Complexity and Fractal Analysis in Heart Rate Dynamics

ÀúÀÚ : ÀÌ»óÈñ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

°æ»ö½É±ÙÀÇ °ü»óµ¿¸Æ ÀçÆó¼âºÎÀ§¿¡ µû¸¥ ¼­·Î ´Ù¸¥ ¾Ð¹Ý»ç¹ÝÀÀ

»ó¼¼º¸±â

Differential Baroreflex Response to a Balloon Occlusion-induced Ischemia in Infarcted Myocardium

ÀúÀÚ : ±èÇüÁØ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

¸¸¼ºÆó¼â¼ºÆóÁúȯ¿¡¼­ ¿ì¿ïÁõ»óÀÇ ºóµµ ¹× À§Çè ÀÎÀÚ

»ó¼¼º¸±â

Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease

ÀúÀÚ : ÁøÇöÁ¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

ÀúGDP Æ÷µµ´ç Åõ¼®¾×ÀÌ ÃÊ¿©°ú¿Í ü¼öºÐ »óÅ ¹× ¿ëÁú Èí¼ö¿¡ ¹ÌÄ¡´Â ¿µÇ⠺м®

»ó¼¼º¸±â

The Effect of low GDP dialysate on Ultrafiltration, Solute Transport and Total Body Water in CAPD Patients

ÀúÀÚ : Àå°æ¾Ö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

ÁÖº¯ºÎÆó¾ÏȯÀÚÀÇ ±â°üÁö¼¼Ã´¾×¿¡¼­ °øÅëÈæ»öÁ¾Ç׿øÀ¯ÀüÀÚÀÇ ¹ßÇö

»ó¼¼º¸±â

The Expression of MAGE in Bronchial Washing in Patients with Peripheral Lung Cancer

ÀúÀÚ : ¹ÚÂù¼­

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

Á¦ 2 Çü ´ç´¢º´È¯ÀÚ¿¡°Ô¼­ Ç÷û ºô¸®·çºó°ú °ü»óµ¿¸Æ Á×»ó°æÈ­ÁõÀÇ °ü°è

»ó¼¼º¸±â

Relationship between serum bilirubin leves and coronary atherosclerosis in patients with type 2 diabetes

ÀúÀÚ : ¹®Áؼº

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

±Þ¼º½É±Ù °æ»öÁõ ȯÀÚ¿¡¼­ ³»¿ø ¾ç»óÀÌ ¿¹ÈÄ¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

Clinical impact of the pre-hospital flow in acute myocardial infarction patients

ÀúÀÚ : °­»ó¿í

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

¾Ç¼º°£¹®ºÎ´ã°ü ÇùÂø ȯÀÚ¿¡¼­ ÆíÃø ´ë ¾çÃø ´ãµµ½ºÅÙÆ®ÀÇ È¿°ú ºñ±³

»ó¼¼º¸±â

The comparison of the effect of unilateral versus bilateral biliary stent in patients with hilar malignancy

ÀúÀÚ : ÀÌ»óÈÆ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2008  

°íÁÖÆÄ·Î ÀýÁ¦ÇÑ °³ÀÇ ½ÉÀå¿¡¼­ Àΰ£ Áö¹æÀ¯·¡ Áٱ⼼Æ÷·ÎºÎÅÍ ½É±Ù¼¼Æ÷·ÎÀÇ À¯µµ ¹× ºÐÈ­

»ó¼¼º¸±â

Homing of adipose-derived stem cells to radiofrequency catheter ablated canine atrium and differentiation into cardiomyocyte-like cells

ÀúÀÚ : ±è¿õ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2009  

Á¦2Çü ´ç´¢º´ÀÇ ¿¹ÃøÁöÇ¥·Î¼­ °øº¹ Ç÷Àå Ç÷´ç°ú ´çÈ­ Ç÷»ö¼ÒÀÇ Á¶ÇÕ

»ó¼¼º¸±â

The combination of fasting plasma glucose and glycosylated hemoglobin as a predictor for type 2 diabetes

ÀúÀÚ : ÀÌÂùÈñ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2009  

±Þ¼º ¹éÇ÷º´ ȯÀÚ¿¡¼­ °üÇØ À¯µµ Ä¡·á ½Ã ÀÏ¹Ý º´½Ç°ú º¸È£µÈ ȯ°æÀÇ °¨¿°À² ºñ±³

»ó¼¼º¸±â

Comparative study of protected environment versus Non-protected environment in acute myeliod leukemia during remission induction chemotherathy

ÀúÀÚ : ¼Õ¼¼ÈÆ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2010  

¶ó¹ÌºÎµò ³»¼º ¸¸¼º BÇü °£Áúȯ¿¡¼­ ¾Æµ¥Æ÷ºñ¾î µðÇǺ¹½ÇÀ» ±âº»À¸·Î ÇÑ ±¸Á¦Ä¡·áÀÇ È¿°ú

»ó¼¼º¸±â

Effectiveness of Adefovir Dipivoxil-Based Rescue Therapy in Lamivudine-Resistant Hepatitis B Virus-Related Liver Disease

ÀúÀÚ : ÀÌÈ£Âù

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2010  

°æ½Äµµ Á¶¿µ ½ÉÃÊÀ½ÆÄ¿¡ ÀÇÇÑ Á½ɹæ Ç÷·ù ¼Ò¿ëµ¹ÀÌÀÇ Æ¯¼ºÈ­

»ó¼¼º¸±â

Characterization of Left Atrial Blood Flow Vorticity By Two-Demensional Transesophageal Contrast Echocardiography Using Particle Image Velocimetry

ÀúÀÚ : ¹Ú±Ôȯ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2010  

È­³ó¼º °£³ó¾ç ¿øÀÎ±Õ ¹× Ç×»ýÁ¦ °¨¼ö¼º ¾ç»óÀÇ º¯È­

»ó¼¼º¸±â

The recent changes of the microorganisms and antibiotics susceptibility of pyogenic liver abscess

ÀúÀÚ : ±è½Â¹ü

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2010  

Ç÷°ü¼¼Æ÷³ëÈ­¿¡ ´ëÇÑ »êÈ­Çü Àú¹Ðµµ ÁöÁú´Ü¹éÁúÀÇ ¿µÇâ

»ó¼¼º¸±â

Effects of oxidized low density lipoprotein on cellular senescence of human vascular cells

ÀúÀÚ : ÀÌ¿øÀç

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2010  

±¹¼Ò ¿¬ºÎÁ¶Á÷ À°Á¾ ȯÀÚÀÇ ¿¹ÈÄ ÀÎÀÚ ºÐ¼®

»ó¼¼º¸±â

Prognostic factors of patients with localized soft tissue sarcoma

ÀúÀÚ : °í¼º¾Ö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2010  

ÁÖº¯ºÎ Æó¾Ï Áø´Ü¿¡¼­ ±â°üÁö¼¼Ã´¾×ÀÇ °øÅëÈæ»öÁ¾Ç׿øÀ¯ÀüÀÚÀÇ À¯¿ë¼º

»ó¼¼º¸±â

The expression of MAGE A1-6 RT-nested PCR in bronchial washing in patients with peripheral lung cancer

ÀúÀÚ : ±è±ÔÁø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2011  

°£°æº¯ ȯÀÚ¿¡¼­ ´ã¼®ÀÇ ¹ß»ýºóµµ¿Í À§ÇèÀÎÀÚ

»ó¼¼º¸±â

The Prevalence and risk factors of gallstones in Korean patients with liver cirrhosis

ÀúÀÚ : ¹ÚÀçÇö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2011  

¸ÞÆ®Æ÷¸£¹Î Åõ¿©°¡ Á¦ 2Çü ´ç´¢º´ ȯÀÚÀÇ ¾Ï ¹ß»ý¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

The effect of metformin on the risk of cancer in patients with T2DM

ÀúÀÚ : Á¤ÇöÈñ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2012  

ÁøÇàµÈ Æó¼±¾Ï È¯ÀÚ¿¡¼­ Paclitaxe/Cisplatin º´ÇÕ¿ä¹ý°ú Pemetrexed/Cisplatin º´ÇÕ¿ä¹ýÀÇ Ä¡·áÈ¿°ú ºñ±³

»ó¼¼º¸±â

Comparison of the efficacy of paclitaxel/cisplatin versus pemetrexed/cisplatin in patients with advanced adenocarcinoma lung cancer

ÀúÀÚ : ¿ì´ëÇü

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2012  

Ãʱ⠳»°úÀûÀ¸·Î Ä¡·áÇÑ ´ëµ¿¸Æ º® ³» Ç÷Á¾ ȯÀÚÀÇ ÀÓ»ó°æ°ú

»ó¼¼º¸±â

Clinical outcomes of medically treated acute aortic intramural hematoma

ÀúÀÚ : °­¹Î±Ô

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2012  

Tissue factor ¹ßÇö¿¡¼­ janus kinase-signal transducer and activator of transcriptionÀÇ ¿ªÇÒ

»ó¼¼º¸±â

Role of janus kinase-signal transducer and activator of transcription for the expression of tissue factor

ÀúÀÚ : ±èÇüÁØ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2012  

ü¼ººÐ ±¸¼ºÀÌ Æó±â´É¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

The effect of body composition on pulmonary function

ÀúÀÚ : ¹ÚÁ¤Àº

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2012  

·ù¸¶Æ¼½º °üÀý¿° ȯÀÚ¿¡¼­ Methotrexate Ä¡·á°¡ °æµ¿¸Æ ³»Á߸· µÎ²²¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

The Effect of Methotrexate on Carotid Artery Intima Media Thickness in Patients with Rheumatoid Arthritis

ÀúÀÚ : ±èÇöÁ¦

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2012  

È°¸·¿°ÀÇ ¿°ÁõÁ¶ÀýÀÎÀڷμ­ 6-O Extracellular Endosulfatase, Sulf-1, Sulf-2ÀÇ ¿ªÇÒ

»ó¼¼º¸±â

Role of 6-O extracellular endosulfatases, sulf-1 and sulf-2, as novel regulators of inflammatory synovitis

ÀúÀÚ : È«¿µÈÆ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2012  

Toll-like receptor 2¿¡ ÀÇÇÑ NADPH oxidase-1 ¹ßÇöÀ» Á¶ÀýÇÏ´Â »õ·Î¿î ½ÅÈ£Àü´Þ °úÁ¤ ±Ô¸í

»ó¼¼º¸±â

Identification of novel signaling pathway for NADPH oxidase-1 expression by toll-like receptor 2

ÀúÀÚ : ¹èÁØÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2012  

À§¾Ï ¼¼Æ÷¿¡¼­ HMGA1À» ÅëÇÑ HGF°ü·Ã ¼¼Æ÷ Áõ½Ä ¹× ÀÚ¸êÀÇ Á¶Àý

»ó¼¼º¸±â

Regulation of hepatocyte growth factor-mediated cell proliferation and apoptosis through high-motility group A 1 in stomach cancer cells

ÀúÀÚ : ÀÌÇÏ¿µ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2013  

³»½Ã°æ Å« dz¼± À¯µÎÈ®Àå¼úÀ» ÀÌ¿ëÇÑ °Å´ë ÃÑ ´ã°ü´ã¼® Á¦°Å¼ú ÈÄ ÃéÀå¿°ÀÇ ¹ß»ý À§Ç輺

»ó¼¼º¸±â

Endoscopic papillary large balloon dilation for the treatment of large bile duct stones may not increase the risk of post-ERCP pancratitis

ÀúÀÚ : ¹ÚÁؼ®

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2013  

±Þ¼ºÃéÀå¿°ÀÇ ÁßÁõµµ Æò°¡ ÁöÇ¥µéÀÇ ºñ±³

»ó¼¼º¸±â

Comparison of scoring systems in predicting the severity of acute pancreatitis

ÀúÀÚ : Á¶ÁØÇö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2013  

±Ë¾ç¼º ´ëÀå¿°ÀÇ ÀÓ»óÀû º¯È­ ¾ç»ó

»ó¼¼º¸±â

Analysis of changes in clinical aspects of ulcerative colitis

ÀúÀÚ : ¼Û¿µµÎ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2013  

À§¾Ï ÀüÀÌ°úÁ¤¿¡¼­ÀÇ VEGF¸¦ ÅëÇÑ RhoGDI2ÀÇ ¿ªÇÒ

»ó¼¼º¸±â

RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer

ÀúÀÚ : °í¼º¾Ö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2013  

»ç¶÷ ¿¬°ñ¼¼Æ÷¿¡¼­ Àú»ê¼ÒÁõ°ú Æ÷µµ´ç ³óµµ ÀúÇÏ°¡ ¿¬°ñÀÌÈ­¹°Áú¿¡ ¹ÌÄ¡´Â ¿µÇâ

»ó¼¼º¸±â

Effects of hypoxia and glucose deprivation on catabolic mediators of cartilage in human chondrocytes

ÀúÀÚ : ¹ÚÂù¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2013  

±ä ¹Ì¸¸¼º °üµ¿¸Æ º´º¯¿¡¼­ ¾à¹° ¹æÃâ ½ºÅÙÆ® »ðÀÔ ÈÄ ÀÓ»ó°æ°ú : 1¼¼´ë¿Í 2¼¼´ë °üµ¿¸Æ º´º¯¿¡¼­ ¾à¹° ¹æÃâ ½ºÅÙÆ® »ðÀÔ ÈÄ ÀÓ»ó°æ°ú

»ó¼¼º¸±â

Two-year clinical and angiographic outcomes of patients with drug-eluting stents in diffuse long lesions : comparison of 1st-generation sirolimus/paclitaxel-eluting stent vs.2nd-generation zotarolimus-/everolimus-eluting stent

ÀúÀÚ : ÃÖÀ±Á¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2013  

¼ºÀΠõ½Ä ȯÀÚ¿¡¼­ Ç÷¼ÒÆÇ È°¼ºÈ­¿Í P2Y12 ¼ö¿ëüÀÇ ¹ßÇö

»ó¼¼º¸±â

Platelet activation with P2Y12 receptor expression in adult asth

ÀúÀÚ : ÁøÇöÁ¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2013  

ÃéÀ庣Ÿ¼¼Æ÷¿¡¼­ ezetimibeÀÇ Æ÷µµ´çµ¶¼º °³¼± È¿°ú

»ó¼¼º¸±â

The glucotoxicity protecting effect of ezetimibe in pancreatic beta cells via inhibition of CD36

ÀúÀÚ : À±Áö¼º

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2013  

¿¬·É °ü·Ã °ñ °üÀý¿°¿¡¼­ ¿¬°ñ ÅðÇà°ú arNOX È°¼ºµµÀÇ °ü°è

»ó¼¼º¸±â

arNOX activity correlated with age and cartilage degeneration

ÀúÀÚ : ±è¹ÎÁ¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2014  

EGFR µ¹¿¬º¯ÀÌ°¡ ÀÖ´Â ÁøÇ༺ Æó¼±¾Ï È¯ÀÚ¿¡¼­ Pemetrexe/Cisplatin°ú Paclitaxel/CisplatinÀÇ ºñ±³

»ó¼¼º¸±â

A Comparative Study of Pemetrexed/Cisplatin versus Paclitaxel/Cisplatin in Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma

ÀúÀÚ : À̵¿¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2014  

BÇü °£¿°¹ÙÀÌ·¯½ºÀÇ ¿ªÀü»çÈ¿¼Ò 181 µ¹¿¬º¯ÀÌ¿¡ ´ëÇÑ ±¸Á¦ Ä¡·á·Î¼­ ÇÙ»ê À¯»çüÀÇ ÀÓ»óÀû È¿°ú : 48ÁÖ °á°ú

»ó¼¼º¸±â

Clinical efficacy of nucleos(t)ide analogues as rescue therapy for rt181 mutants of hepatitis B virus : 48 weeks results

ÀúÀÚ : ¿À¸íÁø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2014  

Á¦2Çü ´ç´¢º´ ȯÀÚ¿¡¼­ÀÇ Ç÷û Fibroblast growth factor 21°ú Àν¶¸° ºÐºñ´É ¹× ´ë»ç ÁöÇ¥ÀÇ °ü·Ã¼º

»ó¼¼º¸±â

The Association of Serum Fibroblast Growth Factor 21 with Insulin Secretory Function and Metabolic Parameters in Type 2 Diabetes

ÀúÀÚ : ¼ÛÀοí

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2014  

ÀÛÀº Á¶Á÷À¸·Î Áø´ÜµÈ Æ󼱾Ͽ¡¼­ ÀÓ»óº´¸®ÇÐÀû Ư¼º°ú »óÇǼ¼Æ÷ ¼ºÀåÀÎÀÚ ¼ö¿ëüÀÇ µ¹¿¬º¯ÀÌ¿Í °ü·Ã¼º

»ó¼¼º¸±â

The Relationship between EGFR mutations and the clinicopathologic features of lung adenocarcinomas diagnosed by small biopsies

ÀúÀÚ : ±èÇöÁ¤

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2014  

Çѱ¹ÀÎ ½É¹æ¼¼µ¿ ȯÀÚ¿¡¼­ Ž½Ä¼¼Æ÷ NADPH »êÈ­È¿¼Ò°èÀÇ À¯ÀüÀÚ ´ÙÇü¼º ºÐ¼® ¹× »êÈ­½ºÆ®·¹½ºÀÇ Á¤·®Àû Æò°¡

»ó¼¼º¸±â

Haplotype analysis of phagocytic NADPH oxidase polymorphisms in Korean atrial fibrillation patients : burden of systemic oxidative stress and it's determinants

ÀúÀÚ : ¼ÕÀå¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2014  

µ¿¸Æ°æÈ­¸¦ Á¶ÀýÇÏ´Â ATP-binding cassette transpoter A1ÀÇ ¹ßÇö±âÀü

»ó¼¼º¸±â

Expression mechanism of atherosclerosis regulator, ATP-binding cassette transporter A1

ÀúÀÚ : °­»ó¿í

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2015  

¾È±¸ ºÎ¼Ó±â¿¡ ¹ß»ýÇÑ MALT ¸²ÇÁÁ¾ : 20³â µ¿¾ÈÀÇ Àå±â°£ ÃßÀû °á°ú

»ó¼¼º¸±â

Orbital and Ocular Adnexal MALT lymphomas : A long-Term outcome for 20 years

ÀúÀÚ : ¹Ú¼º¿ì

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2015  

Á¶ÀýµÇÁö ¾Ê´Â Á¦2Çü ´ç´¢º´¿¡¼­ ºÒÇö¼º °©»ó¼± ±â´É ÀúÇÏÁõÀÇ À¯º´·ü

»ó¼¼º¸±â

Prevalence of subclinical hypothyroidism in poorly controlled type 2 diabetes mellitus

ÀúÀÚ : Á¶ÀçÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2015  

½É¹æ¼¼µ¿¿¡¼­ ¿°Áõ ¹× »êÈ­ ½ºÆ®·¹½ºÀÇ Á¤·®Àû Æò°¡

»ó¼¼º¸±â

The Role of Inflammation and Oxidative Stress in Atrial Fibrillation : Burden of Inflammation and Oxidative Stress and its Determinants

ÀúÀÚ : ³²Á¾È£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2015  

Ç׿°Áõ ÁöÁöüÀÇ »ýü³» Æò°¡¸¦ À§ÇÑ µ¿¹°¸ðµ¨·Î¼­ ÀÎÅÍ·çŲ 10 À¯ÀüÀÚ ºÎÀü ¸¶¿ì½ºÀÇ À¯È¿¼º

»ó¼¼º¸±â

In vivo validation model for a novel anti-inflammatory scaffold on Interleukin-10 knockout mouse

ÀúÀÚ : ÀÌ»óÈÆ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2016  

°Ç°­°ËÁø ¼öÁøÀÚ¿¡¼­ ¼ºº°¿¡ µû¸¥ ´ã³¶ ´ã¼®ÀÇ À¯º´·ü ¹× À§ÇèÀÎÀÚ ºñ±³ : ´Ù±â°ü ÈÄÇâÀû ºÐ¼®

»ó¼¼º¸±â

Gender Differences in Prevalence and Risk Factors of Gallbladder Stone in Korean Health Screening Examinee: A Retrospective Analysis of a Multicenter Study

ÀúÀÚ : ±è½Â¹ü

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2016  

Çѱ¹Àο¡¼­ ´Ü±â°£ ½É¹Úµ¿ º¯À̵µ ÁöÇ¥ÀÇ Á¤»óÄ¡¿Í »ç¸Á¿¹Ãø¿¡ ´ëÇÑ ÀÓ»óÀû À¯¿ë¼º

»ó¼¼º¸±â

Normative Values of the Short-Term Heart Rate Variability Parameters in Koreans and Their Clinical Value for the Prediction of Mortality

ÀúÀÚ : ÀÌÂùÈñ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2016  

·çǪ½º ½Å¿°¿¡¼­ Ç×-ȲȭÇìÆĶõ Ç×üÀÇ »ý¼º°ú »ç±¸Ã¼ ±âÀú¸· ȲȭÇìÆĶõÇÁ·ÎÅ׿À±Û¸®Ä­ÀÇ ±â´ÉÀû ¼Ò½Ç

»ó¼¼º¸±â

Anti-Heparan Sulfate Antibody and Functional Loss of Glomerular Heparan Sulfate Proteoglycans in Lupus Nephritis

ÀúÀÚ : ±èÇöÁ¦

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2016  

X-¼± Åõ½Ã ¾øÀÌ ½ÅÀå³»°ú Àǻ翡 ÀÇÇØ »ðÀÔµÈ ÅͳΠÇ÷¾× Åõ¼® µµ°ü¿¡ ´ëÇÑ ´ÜÀϱâ°ü ¿¬±¸

»ó¼¼º¸±â

Single-center Experience of Tunneled Hemodialysis Catheter Insertion without Fluoroscopy by Nephrologists

ÀúÀÚ : Á¤¿äÇÑ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2016  

Á¦2Çü ´ç´¢º´È¯ÀÚ¿¡¼­ ÀûÇ÷±¸ º¯Çü´É°ú ´ç´¢º´¼º ¸Á¸·ÁõÀÇ »ó°ü°ü°è

»ó¼¼º¸±â

Impaired RBC deformability is Associated with Diabetic Retinopathy in Patients with Type 2 diabetes

ÀúÀÚ : ±èÀçÈ«

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2016  

Å« °ü»óµ¿¸ÆÀÇ ´ÜÀÏ ÇùÂø º´º¯ Ä¡·á¿¡ ÀÖ¾î ¾à¹°¹æÃâ ½ºÅÙÆ®¿Í ±Ý¼Ó ½ºÅÙÆ®ÀÇ 5³â°£ ÀÓ»ó°á°ú ºñ±³

»ó¼¼º¸±â

Five-year Outcomes of Drug Eluting Stents in a Single, Large Coronary Lesion

ÀúÀÚ : Á¶Á¤È¯

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2016  

Çѱ¹Àο¡¼­ Á¶±â À§¾Ï ¹ß°ß¿¡ ´ëÇÑ »ý¹°Ç¥ÁöÀڷμ­ Ç÷û Æ®·¹Æ÷ÀÏ ÀÎÀÚ 3

»ó¼¼º¸±â

Serum Trefoil Factor Family 3 as a Biomarker for the Detection of Early Gastric Cancer in Korean

ÀúÀÚ : ÀÌÇö¼®

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2016  

FDG PET-CT¿¡¼­ ¿ì¿¬È÷ ¹ß°ßµÈ ÁøÇ༺ ´ëÀå Á¾¾çÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¡ ¹× À§ÇèÀÎÀÚ

»ó¼¼º¸±â

Clinicopathological analysis and risk factors of advanced colorectal neoplasms incidentally detected by FDG PET-CT

ÀúÀÚ : Á¤½Â¹Î

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2016  

±¹³» 3Â÷ ´ëÇк´¿ø¿¡ ÀÇ·á±â°ü °ü·Ã Æó·ÅÀ¸·Î ÀÔ¿øÇÑ È¯ÀÚµéÀÇ ÀÓ»óÀû ¾ç»ó ¹× ¿¹ÈÄ À§ÇèÀÎÀÚ

»ó¼¼º¸±â(¿ø¹®ºñ°ø°³)

The Clinical Characteristics and Prognostic Risk Factors of Healthcare-Associated Pneumonia in a Korean Tertiary Teaching Hospital

ÀúÀÚ : ¾ÈÁØÈ«

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2017  

Çѱ¹ÀÇ °¢ ÇüÅÂÀÇ Æó¼â¼º ±âµµÁúȯ¿¡¼­ ±Ù°¨¼ÒÁõ À¯¹«¿¡ µû¸¥ °ñ¹Ðµµ °¨¼Ò¿ÍÀÇ °ü°è

¿ø¹®ºñ°ø°³

The Relationships between the Presence of Sarcopenia and Decreased Bone Mineral Density in each Obstructive Airway Disease Phenotype of Korea

ÀúÀÚ : À̵¿¿ø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2017  

À§¾Ï¼¼Æ÷ ÁÖ¿¡¼­ BAG3°¡ Egr1 °æ·Î¸¦ ÅëÇØ HGF ¸Å°³ ¼¼Æ÷Áõ½Ä, À̵¿ ¹× ħÅõ¿¡ ¹ÌÄ¡´Â ¿µÇâ

¿ø¹®ºñ°ø°³

BAG3 contributes to HGF-mediated cell proliferation, migration and invasion via the Egr1 pathway in gastric cancers

ÀúÀÚ : ÀÌÀçâ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2017  

´ÜÀÏ 3Â÷ ÀÇ·á±â°ü¿¡¼­ÀÇ ´ç´¢º´¼º Á·ºÎÁúȯÀÇ ÁßÁõµµ¿Í Ä¡·á°æÇâÀÇ 15³â °£ º¯È­

»ó¼¼º¸±â

Trends in the Severity and Treatment Modality of Diabetic Foot Ulcer over a 15-year Period at a Single Tertiary Medical Center

ÀúÀÚ : ±èÁßÈñ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2017  

Soluble CD36 ÁöÇ¥¿Í Á¦2Çü ´ç´¢º´ ¹ß»ýÀ§Çè

»ó¼¼º¸±â

The association between soluble CD36 (sCD36) index and the risk of type 2 diabetes

ÀúÀÚ : ±èÈ£Áø

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2017  

ºñ¾ËÄڿüº Áö¹æ°£Áúȯ ȯÀÚ¿¡¼­ °£¼¶À¯È­¿Í ´ëÀå¼±Á¾°úÀÇ °ü°è

»ó¼¼º¸±â

Association between liver fibrosis and colorectal adenoma in patients with non-alcoholic fatty liver disease

ÀúÀÚ : ±è¹Îö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2018  

Á¦2Çü ´ç´¢º´È¯ÀÚ¿¡¼­ ÀÓ°èÀü´ÜÀÀ·Â°ú ´ç´¢º´¼º½ÅÁõÀÇ »ó°ü°ü°è

»ó¼¼º¸±â

Critical shear stress is associated with diabetic kidney disease in patients with type 2 diabetes

ÀúÀÚ : ¿ÀÁ¤Çö

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2018  

Relationship between myocardial perfusion and penetrating intramyocardial coronary artery in patients with apical hypertrophic cardiomyopathy

»ó¼¼º¸±â

½É÷ºÎ ºñÈļº ½É±Ùº´Áõ ȯÀÚ¿¡¼­ ½É±Ù °ü·ù¿Í ½É±Ù °ü»óµ¿¸Æ »çÀÌÀÇ °ü°è

ÀúÀÚ : ÃÖ°­¿î

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2019  

MyricetinÀÇ Àν¶¸° ºÐºñ ÃËÁø°ú thapsigargin µ¶¼º¿¡ ´ëÇÑ ÃéÀå º£Å¸¼¼Æ÷ º¸È£ ÀÛ¿ë

»ó¼¼º¸±â

Myricetin Potentiates Insulin Secretion and Protects Pancreatic ¥â-cells Against Thapsigargin-mediated Toxicity

ÀúÀÚ : ÀÌÁöÀº

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2019  

ÇǸ£Æä´Ïµ·Àº TGF-¥â ¹× Smad ÀÇÁ¸¼º ½ÅÈ£ Àü´Þ °æ·Î¿Í ºñÀÇÁ¸¼º ½ÅÈ£ Àü´Þ °æ·Î¸¦ ÇÏÇâÁ¶ÀýÇÔÀ¸·Î½á º¹¸·ÁßÇǼ¼Æ÷ÀÇ »óÇÇÁß°£¿±¼¼Æ÷ ÀüÀ̸¦ ¾ïÁ¦ÇÑ´Ù.

»ó¼¼º¸±â

Pirfenidone inhibits epithelial to mesenchymal transition in peritoneal mesothelial cells via downregulation of transforming growth factor-¥â/Smad-dependent and Smad-independent signaling pathways

ÀúÀÚ : ¼­ÁØÇõ

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2019  

¼¼¶ó¸¶ÀÌµå ¸Å°³ º£Å¸¼¼Æ÷ºÎÀü¿¡ ÀÖ¾î CD36 ÀÇÁ¸ Redoxosomes°ú p66Shc È°¼ºÈ­ÀÇ ±âÀü¿¡ ´ëÇÑ ¿¬±¸

»ó¼¼º¸±â

CD36 Dependent Redoxosomes Promotes Ceramide-mediated Pancreatic ¥â-cell failure via p66Shc activation

ÀúÀÚ : ¹®Áؼº

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2019  

±Ù°¨¼ÒÁõ°ú ¿µ»óÇÐÀû ½½°üÀý°­ÇùÂø: ±¹¹Î°Ç°­¿µ¾çÁ¶»ç Á¦4±â¿Í Á¦5±â (KNHANES ? IV and V) °á°ú¸¦ Åä´ë·Î

»ó¼¼º¸±â

Sarcopenia and knee joint space narrowing: according to the 4th and the 5th Korea National Health and Nutrition Examination Survey (KNHANES ? IV and V)

ÀúÀÚ : ¹è»ó¿î

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2019  

Prognostic Factors Affecting Amputation in Diabetic Foot

»ó¼¼º¸±â

´ç´¢º´¼º Á·ºÎ º´º¯ÀÇ Àý´Ü ¿¹ÈÄÀÎÀÚ

ÀúÀÚ : ÀÌÁØÈ£

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¼®»ç ¿¬µµ : 2020  

The 14-3-3 sigma contributes to hepatocyte growth factor-mediated cell proliferation and invasion by Matrix metalloproteinase-1 regulation in human gastric cancer

»ó¼¼º¸±â

Àΰ£ À§¾Ï ¼¼Æ÷¿¡¼­ 14-3-3 sigma°¡ MMP-1 °æ·Î¸¦ ÅëÇØ HGF ¸Å°³ ¼¼Æ÷Áõ½Ä°ú ħÅõ¿¡ ¹ÌÄ¡´Â ¿µÇâ

ÀúÀÚ : Á¤ÁöÀ±

Àü°ø : ³»°úÇÐÀü°ø ÇÐÀ§ : ¹Ú»ç ¿¬µµ : 2020